ID29790A - USE OF IMIDAZO (1,5-a) -PIRIDO (3,2-e) -PIRAZINON AS MEDICINE - Google Patents

USE OF IMIDAZO (1,5-a) -PIRIDO (3,2-e) -PIRAZINON AS MEDICINE

Info

Publication number
ID29790A
ID29790A IDW00200101592A ID20011592A ID29790A ID 29790 A ID29790 A ID 29790A ID W00200101592 A IDW00200101592 A ID W00200101592A ID 20011592 A ID20011592 A ID 20011592A ID 29790 A ID29790 A ID 29790A
Authority
ID
Indonesia
Prior art keywords
pirazinon
pirido
imidazo
medicine
Prior art date
Application number
IDW00200101592A
Other languages
Indonesian (id)
Inventor
Hofgen Norbert
Szelenyi Stefan
Degenhard Marx
Egerland Ute
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999102082 external-priority patent/DE19902082A1/en
Priority claimed from DE1999161302 external-priority patent/DE19961302A1/en
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of ID29790A publication Critical patent/ID29790A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW00200101592A 1999-01-20 2000-01-14 USE OF IMIDAZO (1,5-a) -PIRIDO (3,2-e) -PIRAZINON AS MEDICINE ID29790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999102082 DE19902082A1 (en) 1999-01-20 1999-01-20 New and known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, useful as phosphodiesterase 5 inhibitors for treating erectile dysfunction
DE1999161302 DE19961302A1 (en) 1999-12-18 1999-12-18 Treatment of erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinones as phosphodiesterase inhibitors, some of which are also useful for treating cardiovascular disorders

Publications (1)

Publication Number Publication Date
ID29790A true ID29790A (en) 2001-10-11

Family

ID=26051406

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101592A ID29790A (en) 1999-01-20 2000-01-14 USE OF IMIDAZO (1,5-a) -PIRIDO (3,2-e) -PIRAZINON AS MEDICINE

Country Status (23)

Country Link
EP (1) EP1144410A2 (en)
JP (1) JP2002535330A (en)
KR (1) KR20010101603A (en)
CN (1) CN1344268A (en)
AR (1) AR022318A1 (en)
AU (1) AU2291200A (en)
BG (1) BG105714A (en)
BR (1) BR0007613A (en)
CA (1) CA2296224A1 (en)
CO (1) CO5190700A1 (en)
CZ (1) CZ20012627A3 (en)
EA (1) EA200100792A1 (en)
EE (1) EE200100377A (en)
HU (1) HUP0105132A3 (en)
ID (1) ID29790A (en)
IL (1) IL144156A0 (en)
IS (1) IS5987A (en)
LT (1) LT2001078A (en)
LV (1) LV12793B (en)
NO (1) NO20013334D0 (en)
SK (1) SK10322001A3 (en)
TR (1) TR200102121T2 (en)
WO (1) WO2000043392A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
WO2003051346A2 (en) * 2001-12-17 2003-06-26 Altana Pharma Ag Use of selective pde5 inhibitors for treating partial and global respiratory failure
FR2835741B1 (en) * 2002-02-12 2006-05-05 Oreal NOVEL 6-ALCOXY-2,3-DIAMINOPYRIDINE COUPLINGS USEFUL FOR DYING KERATIN FIBERS
US6916345B2 (en) 2002-02-12 2005-07-12 L'oreal S.A. 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres
DE10325813B4 (en) 2003-06-06 2007-12-20 Universitätsklinikum Freiburg Prophylaxis and / or therapy in portal hypertension
JP5070052B2 (en) * 2004-08-17 2012-11-07 ザ・ジョンズ・ホプキンス・ユニバーシティ PDE5 inhibitor composition and method for treating heart disease
ES2566774T3 (en) * 2006-12-13 2016-04-15 Aska Pharmaceutical Co., Ltd. Quinoxaline derivative
JP2011505366A (en) 2007-11-30 2011-02-24 ワイス・エルエルシー Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphoesterase 10
US20090143361A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
IN2015DN02829A (en) 2011-10-10 2015-09-11 Lundbeck & Co As H
WO2013110768A1 (en) 2012-01-26 2013-08-01 H. Lundbeck A/S Pde9 inhibitors with imidazo triazinone backbone
JP5842640B2 (en) * 2012-01-31 2016-01-13 株式会社東洋新薬 Phosphodiesterase 3 inhibitor
WO2016022836A1 (en) * 2014-08-07 2016-02-11 Intra-Cellular Therapies, Inc. Organic compounds
US9938284B2 (en) 2014-08-07 2018-04-10 Intra-Cellular Therapies, Inc. Organic compounds
BR112018000254A2 (en) 2015-07-07 2018-09-04 H Lundbeck As pde9 inhibitors with imidazotriazinone main chain and imidazopyrazinone main chain for the treatment of peripheral diseases
HUE065709T2 (en) 2018-05-25 2024-06-28 Cardurion Pharmaceuticals Inc Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
DE19510965A1 (en) * 1995-03-24 1996-09-26 Asta Medica Ag New pyrido / 3,2-e / pyrazinone with anti-asthmatic activity and process for their preparation

Also Published As

Publication number Publication date
CZ20012627A3 (en) 2002-01-16
EE200100377A (en) 2002-10-15
EP1144410A2 (en) 2001-10-17
TR200102121T2 (en) 2002-01-21
KR20010101603A (en) 2001-11-14
JP2002535330A (en) 2002-10-22
BG105714A (en) 2002-02-28
CN1344268A (en) 2002-04-10
AR022318A1 (en) 2002-09-04
IS5987A (en) 2001-06-29
IL144156A0 (en) 2002-05-23
WO2000043392A2 (en) 2000-07-27
WO2000043392A3 (en) 2000-09-28
NO20013334L (en) 2001-07-05
AU2291200A (en) 2000-08-07
CO5190700A1 (en) 2002-08-29
HUP0105132A3 (en) 2002-12-28
LV12793A (en) 2002-02-20
EA200100792A1 (en) 2002-10-31
CA2296224A1 (en) 2000-07-20
LT2001078A (en) 2002-08-26
LV12793B (en) 2002-05-20
SK10322001A3 (en) 2002-07-02
NO20013334D0 (en) 2001-07-05
HUP0105132A2 (en) 2002-05-29
BR0007613A (en) 2001-10-30

Similar Documents

Publication Publication Date Title
MXPA02002898A (en) Pyrazolopyrimidines as therapeutic agents.
ID29790A (en) USE OF IMIDAZO (1,5-a) -PIRIDO (3,2-e) -PIRAZINON AS MEDICINE
NO20014379D0 (en) Use of Xenon for the Treatment of Neurointoxics
DE60024988D1 (en) PREPARATION OF THERAPEUTIC MICROSCIENTS
EP1545545A4 (en) COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS
HK1045814A1 (en) New use of compounds as antibacterial agents.
HUP0204143A3 (en) Tricyclic 1-benzylpyrazole-3-carboxylic acid derivatives, preparation of the compounds, their use and pharmaceutical compositions containing them
DE60103909D1 (en) 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO [1,2-A] PYRIMIDIN-4-ON- AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO [1,2-A] PYRIMIDIN-5 1HON DERIVATIVES
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
NO20013645L (en) Use of Pyridazino [4,5-b] Indole-1-Acetamide Derivatives for the Preparation of Medicines for the Treatment of Disease-Related Dysfunction of the Peripheral Benzodiazepine Receptors
MXPA03008965A (en) Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments.
EE200200305A (en) Novel azabicyclooctane derivatives used in the treatment of cardiac arrhythmias
HK1036274A1 (en) Imidazo (1,2-a) pyridine derivatives for the treatment of gastrointestinal diseases
SI1560830T1 (en) Derivatives of (6, 7-dihydro-5h-imidazo(1,2 - a)imidazole -3 -sulfonylamino)-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
ATE251162T1 (en) TRIAZOLO(4,5-D)PYRIMIDINE COMPOUNDS
MXPA03008894A (en) Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments.
NO20012541D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20001894L (en) Use of TNF antagonists as drugs for the treatment of septic diseases
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
HUP0203900A3 (en) Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
NO20000805D0 (en) Process for the preparation of organic azides
AU1022501A (en) Use of compositions for the caring treatment of the skin
NO20012540D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20016271D0 (en) Process for the preparation of substituted [1,4] diazepino [6,7,1-hi] indol-4-ones